Warning signs such as fatigue, frequent infections and unexplained bruising may require greater medical attention.Warning signs such as fatigue, frequent infections and unexplained bruising may require greater medical attention.

Leukaemia: early symptoms and the importance of timely care

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com
ribbonOrange ribbons are often used to raise awareness about leukaemia and the importance of early detection. (Envato Elements pic)

PETALING JAYA: Leukaemia, a cancer of the blood and bone marrow, remains among the top 10 most common cancers in Malaysia.

The disease broadly falls into two categories: acute and chronic. Acute forms develop quickly and require prompt diagnosis and treatment, while chronic types progress more slowly and may sometimes be monitored before treatment begins.

Regardless of type, early detection plays a crucial role in improving outcomes. But it can be hard to detect.

Unlike many other cancers, leukaemia does not form a visible lump or tumour. There is also no routine population screening programme. Diagnosis often depends on recognising early symptoms and confirming them through a simple blood test.

The challenge is that many early warning signs can be subtle and easily mistaken for common illnesses or everyday fatigue. People may dismiss symptoms or rely on home remedies, delaying medical evaluation.

This can be particularly problematic in rural or remote areas, where access to healthcare information and diagnostic facilities may be limited. In addition, public awareness of blood cancers in Malaysia remains relatively low compared with more widely discussed cancers such as breast, lung or colorectal cancer.

Recognising early symptoms can make a significant difference. Some common warning signs include:

  • persistent fatigue or weakness;
  • recurrent or prolonged fever;
  • frequent infections;
  • easy bruising or bleeding;
  • unexplained weight loss;
  • swollen lymph nodes;
  • bone or joint pain;
  • pale skin.

In some cases, leukaemia may not cause obvious symptoms in its early stages. However, a simple full blood count test can often provide early clues and prompt further investigation.

Treatment has come a long way

A common misconception is that all blood cancers are fatal. In reality, treatment outcomes have improved significantly in recent years; in fact, certain types of leukaemia – particularly some subtypes and childhood cases – are now considered potentially curable.

While leukaemia may not have obvious symptoms, a simple full blood count test can provide early clues. (Envato Elements pic)

Advances in diagnostics have also improved doctors’ ability to identify and classify blood cancers more accurately. Modern testing methods include flow cytometry, genetic analysis, and molecular testing, which help doctors tailor treatment to individual patients.

Treatment options have expanded as well. Many patients now benefit from targeted therapies, improved supportive care, and infection prevention measures.

In addition, stem-cell transplantation programmes have become more advanced, while emerging treatments such as CAR T-cell therapy are beginning to offer new hope for selected patients.

Awareness can save lives

Raising public awareness is key to improving early detection. Global initiatives such as blood cancer awareness month every September play a part.

In Malaysia, public healthcare facilities such as klinik kesihatan and government hospitals regularly conduct sessions to help communities identify warning signs and seek timely care.

NGOs and private-sector groups also play an important role. Organisations such as the National Cancer Society Malaysia and Majlis Kanser Nasional (Makna) organise outreach programmes, social media campaigns, and free or subsidised health screenings.

As leukaemia continues to affect Malaysians of all ages, staying alert to early symptoms can make a lifesaving difference. Parents, teachers, employers and community leaders all have a role to play in encouraging timely medical check-ups and not dismissing symptoms as minor or harmless.

This article was written by Dr Farzana Rizwan and Dr Imam Shaik from the School of Medicine, Faculty of Health and Medical Sciences, Taylor’s University.

World Cup Combo: Aim for 200x

World Cup Combo: Aim for 200xWorld Cup Combo: Aim for 200x

Combine up to 20 World Cup matches in one order

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Not a loophole: Singapore AI export controls let China tap US AI legally

Not a loophole: Singapore AI export controls let China tap US AI legally

American AI technology is reaching Chinese tech giants through a route that US export controls were never designed to close: Singapore. The city-state sits outside
Share
The Cryptonomist2026/07/10 14:46
CME Group to launch Solana and XRP futures options in October

CME Group to launch Solana and XRP futures options in October

The post CME Group to launch Solana and XRP futures options in October appeared on BitcoinEthereumNews.com. CME Group is preparing to launch options on SOL and XRP futures next month, giving traders new ways to manage exposure to the two assets.  The contracts are set to go live on October 13, pending regulatory approval, and will come in both standard and micro sizes with expiries offered daily, monthly and quarterly. The new listings mark a major step for CME, which first brought bitcoin futures to market in 2017 and added ether contracts in 2021. Solana and XRP futures have quickly gained traction since their debut earlier this year. CME says more than 540,000 Solana contracts (worth about $22.3 billion), and 370,000 XRP contracts (worth $16.2 billion), have already been traded. Both products hit record trading activity and open interest in August. Market makers including Cumberland and FalconX plan to support the new contracts, arguing that institutional investors want hedging tools beyond bitcoin and ether. CME’s move also highlights the growing demand for regulated ways to access a broader set of digital assets. The launch, which still needs the green light from regulators, follows the end of XRP’s years-long legal fight with the US Securities and Exchange Commission. A federal court ruling in 2023 found that institutional sales of XRP violated securities laws, but programmatic exchange sales did not. The case officially closed in August 2025 after Ripple agreed to pay a $125 million fine, removing one of the biggest uncertainties hanging over the token. This is a developing story. This article was generated with the assistance of AI and reviewed by editor Jeffrey Albus before publication. Get the news in your inbox. Explore Blockworks newsletters: Source: https://blockworks.co/news/cme-group-solana-xrp-futures
Share
BitcoinEthereumNews2025/09/17 23:55
Iran’s army chief warns of ‘total destruction’ for ground invasion

Iran’s army chief warns of ‘total destruction’ for ground invasion

The post Iran’s army chief warns of ‘total destruction’ for ground invasion appeared on BitcoinEthereumNews.com. Iran’s army chief warned of “total destruction”
Share
BitcoinEthereumNews2026/04/02 18:15

Activate to Enjoy Special Perks

Activate to Enjoy Special PerksActivate to Enjoy Special Perks

Access 0 fees, premium support, and loss coverage.